Medicare Part D Reporting Requirements and Supporting Regulations in MMA Title I, Part 423, section 423.514 (CMS-10185)

ICR 201806-0938-006

OMB: 0938-0992

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2018-12-07
Supplementary Document
2018-06-14
Supplementary Document
2018-06-14
Supporting Statement A
2018-12-07
IC Document Collections
IC ID
Document
Title
Status
8853 Modified
ICR Details
0938-0992 201806-0938-006
Historical Active 201609-0938-008
HHS/CMS CM-CPC
Medicare Part D Reporting Requirements and Supporting Regulations in MMA Title I, Part 423, section 423.514 (CMS-10185)
Revision of a currently approved collection   No
Regular
Approved with change 12/07/2018
Retrieve Notice of Action (NOA) 06/15/2018
  Inventory as of this Action Requested Previously Approved
12/31/2021 36 Months From Approved 01/31/2020
13,603 0 11,438
17,365 0 14,750
0 0 818,775

MMA provides CMS the statutory authority to require all Part D Sponsors (MA-PDs and PDPs) to report data related to their operational costs and services. These data will be analyzed for oversight and monitoring purposes, as well as potentially initiating other groups within the agency to perform functions such as fraud/waste/abuse investigations, audit activities, and compliance. Title I, Part 423, ?423.514 describes CMS' regulatory authority to establish reporting requirements for Part D sponsors. It is noted that each Part D plan sponsor must have an effective procedure to develop, compile, evaluate, and report to CMS, to its enrollees, and to the general public, at the times and in the manner that CMS requires, statistics in the following areas: (1) The cost of its operations. (2) The patterns of utilization of its services. (3) The availability, accessibility, and acceptability of its services. (4) Information demonstrating that the Part D plan sponsor has a fiscally sound operation. (5) Other matters that CMS may require. Subsection 423.505 of the MMA regulation establishes as a contract provision that Part D Sponsors must comply with the reporting requirements for submitting drug claims and related information to CMS.

Statute at Large: 1 Stat. 423 Name of Statute: null
  
None

Not associated with rulemaking

  83 FR 8679 02/28/2018
83 FR 26691 06/08/2018
Yes

1
IC Title Form No. Form Name
Medicare Part D Reporting Requirements

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 13,603 11,438 0 2,726 -561 0
Annual Time Burden (Hours) 17,365 14,750 0 3,176 -561 0
Annual Cost Burden (Dollars) 0 818,775 0 0 -818,775 0
Yes
Miscellaneous Actions
No
For the CY2019 Reporting Requirements, we removed the Retail, Home Infusion and Long-Term Care Pharmacy Access section since the data are no longer necessary for monitoring through these reporting requirements. There was an overall increase in contract respondents (from 561 to 627) and plan respondents (from 4,036 to 5,234) due to an increase in the total number of Part D contracts. Overall, there was an increase in responses (from 11,438 to 13,603) and total time (from 14,750 hr to 17,365 hr).

$300,000
No
    No
    No
No
No
No
Uncollected
Mitch Bryman 410 786-5258 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
06/15/2018


© 2024 OMB.report | Privacy Policy